Drug Patents owned by Therapeuticsmd Inc

1. Drug name - ANNOVERA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10765628 THERAPEUTICSMD INC Method of providing birth control Feb, 2039

(16 years from now)

US10780047 THERAPEUTICSMD INC Method of providing birth control Feb, 2039

(16 years from now)

US10632066 THERAPEUTICSMD INC Method of providing birth control Feb, 2039

(16 years from now)

US10918649 THERAPEUTICSMD INC System for providing birth control Jun, 2039

(16 years from now)

US10925882 THERAPEUTICSMD INC System for providing birth control Jun, 2039

(16 years from now)

US10940157 THERAPEUTICSMD INC System for providing birth control Jun, 2039

(16 years from now)

Drugs and Companies using ETHINYL ESTRADIOL; SEGESTERONE ACETATE ingredient

Treatment: Method of preventing pregnancy by inserting a vaginal system containing 103 mg of segesterone acetate and 17.4 mg ethinyl estradiol into a vagina for up to thirteen 21/7-day (in/out) cycles; method of contraception by inserting a vaginal system for up to 13 21/7-day (in/out) cycles, wherein efficacy requires the system cannot be out of the vagina for more than 2 cumulative hours in any such cycle without using alternative contraception; Method of contraception by inserting a vaginal system for up to 13 21/7-day (in/out) cycles, wherein efficacy requires the system cannot be out of the vagina for more than 2 cumulative hours in any such cycle without using alternative contraception; method of preventing pregnancy by inserting a vaginal system containing 103 mg of segesterone acetate and 17.4 mg ethinyl estradiol into a vagina for up to thirteen 21/7-day (in/out) cycles

Dosage: RING;VAGINAL

More Information on Dosage
Strength Dosage Availability
0.013MG/24HR;0.15MG/24HR RING;VAGINAL Prescription

2. Drug name - BIJUVA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10206932 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US8846649 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US8846648 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US9114146 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US9114145 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US10675288 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US9301920 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US11033626 THERAPEUTICSMD INC Progesterone formulations having a desirable pk profile Nov, 2032

(10 years from now)

US9006222 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US10806740 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US11103513 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US8933059 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US11166963 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US8633178 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US8987237 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US8993549 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US11110099 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US8993548 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US11103516 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies Nov, 2032

(10 years from now)

US10052386 THERAPEUTICSMD INC Progesterone formulations Nov, 2032

(10 years from now)

US10639375 THERAPEUTICSMD INC Progesterone formulations Nov, 2032

(10 years from now)

Drugs and Companies using ESTRADIOL; PROGESTERONE ingredient

Treatment: Treatment of menopause symptoms, including vasomotor symptoms

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
0.5MG;100MG CAPSULE;ORAL Prescription
1MG;100MG CAPSULE;ORAL Prescription

3. Drug name - IMVEXXY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10835487 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods Nov, 2032

(10 years from now)

US10537581 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods Nov, 2032

(10 years from now)

US11246875 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods Nov, 2032

(10 years from now)

US11241445 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods Nov, 2032

(10 years from now)

US9289382 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods Nov, 2032

(10 years from now)

US10806697 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods Nov, 2032

(10 years from now)

US10668082 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods Jun, 2033

(10 years from now)

US10568891 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods Jun, 2033

(10 years from now)

US11116717 THERAPEUTICSMD INC Soluble estradiol capsule for vaginal insertion Jun, 2033

(10 years from now)

US10471072 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods Jun, 2033

(10 years from now)

US11123283 THERAPEUTICSMD INC Soluble estradiol capsule for vaginal insertion Jun, 2033

(10 years from now)

US11065197 THERAPEUTICSMD INC Soluble estradiol capsule for vaginal insertion Jun, 2033

(10 years from now)

US10888516 THERAPEUTICSMD INC Soluble estradiol capsule for vaginal insertion Jun, 2033

(10 years from now)

US9180091 THERAPEUTICSMD INC Soluble estradiol capsule for vaginal insertion Dec, 2033

(11 years from now)

US10258630 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods Dec, 2033

(11 years from now)

US10398708 THERAPEUTICSMD INC Vaginal inserted estradiol pharmaceutical compositions and methods Dec, 2033

(11 years from now)

Drugs and Companies using ESTRADIOL ingredient

Treatment: Treatment of dyspareunia; treatment of a symptom of vulvar and vaginal atrophy; Treatment of a symptom of vulvar and vaginal atrophy; treatment of dyspareunia; Treatment of a symptom of vulvar and vaginal atrophy; treatment of moderate to severe dyspareunia

Dosage: INSERT;VAGINAL

More Information on Dosage
Strength Dosage Availability
0.004MG INSERT;VAGINAL Prescription
0.01MG INSERT;VAGINAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.